PulseExploreJournal ClubTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 23, 2026DNA and Cell Biology

Beyond the Tumor Mass: From Initiating Clones to Overt Isocitrate Dehydrogenase-Mutant Gliomas

View Full Paper
Ask AI
Bookmark
Share

Authors

JPJung Won ParkJLJeong Ho LeeSKSeok‐Gu Kang

Discussion

Loading...

Member takes

Overview

Essay discusses IDH-mutant gliomas' evolution, revealing cell-of-origin implications for therapeutic strategies.

Key Points

  • This research reviews the emerging understanding of IDH-mutant gliomas and their cellular dynamics beyond the tumor mass.
  • Review of data related to IDH-mutant gliomas and their epigenetic characteristics.
  • Discussion of the differences between cell-of-mutation and cell-of-origin.
  • Exploration of therapeutic strategies based on tumor evolution.
  • IDH-mutant gliomas are shaped by a complex interplay of genetic and epigenetic factors.
  • Cells with IDH mutations can persist in normal brain tissue, influencing tumor progression.
  • Understanding tumor evolution may enhance stage-specific therapeutic approaches.

Cite This Study

Park et al. (2026) studied this question.

synapsesocial.com/papers/69c08b9fa48f6b84677f9228https://doi.org/10.1177/10445498261435336
View Full Paper
Ask AI
Bookmark
Share